Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - alanine 11 mg/ml; arginine 8.5 mg/ml; glycine 11 mg/ml; histidine 2.6 mg/ml; isoleucine 6.2 mg/ml; leucine 8.1 mg/ml; lysine 6.24 mg/ml; methionine 3.4 mg/ml; phenylalanine 3.8 mg/ml; proline 7.5 mg/ml; serine 3.7 mg/ml; threonine 4.6 mg/ml; tryptophan 1.5 mg/ml; tyrosine 0.44 mg/ml; valine 6.8 mg/ml - solution for infusion - 8.5 % - active: alanine 11 mg/ml arginine 8.5 mg/ml glycine 11 mg/ml histidine 2.6 mg/ml isoleucine 6.2 mg/ml leucine 8.1 mg/ml lysine 6.24 mg/ml methionine 3.4 mg/ml phenylalanine 3.8 mg/ml proline 7.5 mg/ml serine 3.7 mg/ml threonine 4.6 mg/ml tryptophan 1.5 mg/ml tyrosine 0.44 mg/ml valine 6.8 mg/ml

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine,arginine,aspartic acid,calcium chloride dihydrate,glucose monohydrate,glutamic acid,glycine,histidine,isoleucine,leucine,lysine hydrochloride,magnesium sulfate heptahydrate,methionine,phenylalanine,potassium chloride,proline,serine,sodium acetate trihydrate,sodium glycerophosphate,soya oil,threonine,tryptophan,tyrosine,valine -

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi - phenylalanine; proline; glucose monohydrate; tryptophan; zinc sulfate heptahydrate; soya oil; calcium chloride dihydrate; methionine; histidine; isoleucine; serine; fish oil, rich in omega-3 acids; lysine acetate; sodium glycerophosphate hydrate; leucine; arginine; potassium chloride; valine; taurine; threonine; triglycerides medium chain; glycine; tyrosine; olive oil; magnesium sulfate; alanine; sodium acetate trihydrate - emulsion for infusion - phenylalanine 1.6 mg/ml; proline 3.5 mg/ml; glucose monohydrate; tryptophan 0.63 mg/ml; zinc sulfate heptahydrate; soya oil 8.5 mg/ml; calcium chloride dihydrate; methionine 1.3 mg/ml; histidine 0.93 mg/ml; isoleucine 1.6 mg/ml; serine 2.1 mg/ml; fish oil, rich in omega-3 acids 4.2 mg/ml; lysine acetate; sodium glycerophosphate hydrate; leucine 2.3 mg/ml; arginine 3.8 mg/ml; potassium chloride 1.4 mg/ml; valine 2 mg/ml; taurine 0.32 mg/ml; threonine 1.4 mg/ml; triglycerides medium chain 8.5 mg/ml; glycine 3.5 mg/ml; tyrosine 0.12 mg/ml; olive oil 7 mg/ml; magnesium sulfate 0.38 mg/ml; alanine 4.4 mg/ml; sodium acetate trihydrate - combinations

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sulfamethoxazole 80 mg/ml; trimethoprim 16 mg/ml - solution for injection - 480 mg/5ml - active: sulfamethoxazole 80 mg/ml trimethoprim 16 mg/ml excipient: propylene glycol purified water

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - amoxicillin trihydrate 28.7 mg/ml equivalent to amoxycillin 25 mg/ml;  ; potassium clavulanate 8.6 mg/ml equivalent to clavulanic acid 6.25 mg/ml (plus 13% overage);  ;   - powder for oral suspension - 125mg,31.25mg/5ml - active: amoxicillin trihydrate 28.7 mg/ml equivalent to amoxycillin 25 mg/ml   potassium clavulanate 8.6 mg/ml equivalent to clavulanic acid 6.25 mg/ml (plus 13% overage)     excipient: aspartame citric acid guar gum hydrated silica lemon flavour 15020598 orange flavour 055301 ap0551 peach-apricot flavour 26f22 purified talc sodium citrate - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis and post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxycillin susceptible organisms are amenable to amoxycillin/clavulanic acid treatment due to its amoxycillin content. mixed infections caused by amoxycillin susceptible organisms in conjunction with amoxycillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxycillin/clavulanic acid.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - gemcitabine hydrochloride 11.39 mg/ml equivalent to gemcitabine 10 mg/ml;   - concentrate for injection - 10 mg/ml - active: gemcitabine hydrochloride 11.39 mg/ml equivalent to gemcitabine 10 mg/ml   excipient: sodium acetate trihydrate sodium hydroxide water for injection - non-small cell lung cancer: gemcitabine ebewe, alone or in combination with cisplatin, is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - hydroxocobalamin acetate 1 mg/ml - solution for injection - 1 mg/ml - active: hydroxocobalamin acetate 1 mg/ml excipient: acetic acid sodium acetate sodium chloride water for injection - addisonian pernicious anaemia. prophylaxis and treatment of other macrocytic anaemias associated with vitamin b12 deficiency. tobacco amblyopia and leber's optic atrophy.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

paragon care group new zealand limited - isoleucine 5.6 mg/ml; leucine 8.8 mg/ml; lysine 6.4 mg/ml; methionine 8.8 mg/ml; phenylalanine 8.8 mg/ml; threonine 4 mg/ml; tryptophan 2 mg/ml; valine 6.5 mg/ml - solution for infusion - 5.4 % - active: isoleucine 5.6 mg/ml leucine 8.8 mg/ml lysine 6.4 mg/ml methionine 8.8 mg/ml phenylalanine 8.8 mg/ml threonine 4 mg/ml tryptophan 2 mg/ml valine 6.5 mg/ml excipient: sodium bisulfite water for injection

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

abbvie limited - ritonavir 80 mg/ml - oral solution - 80 mg/ml - active: ritonavir 80 mg/ml excipient: caramel citric acid ethanol peppermint oil polyoxyl 35 castor oil propylene glycol purified water saccharin sodium sunset yellow fcf - norvir is indicated for use in combination with appropriate antiretroviral agents or as monotherapy if combination therapy is inappropriate, for the treatment of hiv-1 infection in adults and children aged 12 years and older. for persons with advanced hiv disease, the indication for ritonavir is based on the results for one study that showed a reduction in both mortality and aids defining clinical events for patients who received ritonavir. median duration of follow-up in this study was 6 months. the clinical benefit from ritonavir for longer periods of treatment is unknown. for persons with less advanced disease, the indication is based on changes in surrogate markers in controlled trials of up to 16 weeks duration.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - linezolid 20 mg/ml - granules for oral suspension - 20 mg/ml - active: linezolid 20 mg/ml excipient: ammonium glycyrrhizinate aspartame citric acid monohydrate colloidal silicon dioxide dispersible cellulose sweet-am powder #918.005 nor-cap natural & artificial orange cream mannitol orange flavour (cream) 884.010 orange flavour 884.114 peppermint flavour sd f93125 sodium benzoate sodium chloride sodium citrate dihydrate sucrose sweet flavour (am) 918.005 vanilla flavour 712729 (mc008927) xanthan gum - zyvox is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · pneumonia - community acquired and nosocomial pneumonia · skin and soft tissue infections · enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.